Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China.

MLA

Pan, Calvin Q., et al. “Long-Term Safety of Infants from Mothers with Chronic Hepatitis B Treated with Tenofovir Disoproxil in China.” Gut, vol. 71, no. 4, Apr. 2022, pp. 798–806. EBSCOhost, https://doi.org/10.1136/gutjnl-2020-322719.

APA

Pan, C. Q., Erhei Dai, Zhongping Duan, Guorong Han, Wenjing Zhao, Yuming Wang, Huaihong Zhang, Baoshen Zhu, Hongxiu Jiang, Shuqin Zhang, Xiaohu Zhang, Huaibin Zou, Xiuli Chen, & Yu Chen. (2022). Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China. Gut, 71(4), 798–806. https://doi.org/10.1136/gutjnl-2020-322719

Chicago

Pan, Calvin Q., Erhei Dai, Zhongping Duan, Guorong Han, Wenjing Zhao, Yuming Wang, Huaihong Zhang, et al. 2022. “Long-Term Safety of Infants from Mothers with Chronic Hepatitis B Treated with Tenofovir Disoproxil in China.” Gut 71 (4): 798–806. doi:10.1136/gutjnl-2020-322719.